Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine OD in moderate to severe Alzheimer's Disease
NCT00624026Phase 3Completed
- Sponsor
- Merz
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in Alzheimer's disease (AD), sponsored by Merz. Started Nov 2007; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00624026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624026.